Changes to PBS restrictions for antidepressants backed

PBAC makes recommendation to amend 30-day solid oral dosage-form listings for several low-cost antidepressants from restricted to unrestricted benefits  Amendments to the Pharmaceutical Benefits Scheme (PBS) listing restrictions for 14 antidepressants will improve access to treatments, the Pharmaceutical Benefits Advisory Committee says.  In its September 2026 meeting outcomes, PBAC recommended amending the current restricted benefit listings for 30-day